|Bid||6.54 x 400|
|Ask||6.58 x 100|
|Day's Range||6.51 - 6.84|
|52 Week Range||5.12 - 10.39|
|PE Ratio (TTM)||1,090.00|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Private equity-backed Canadian medical marijuana company Tilray Inc (NasdaqGS:TLRY - News) rose more than 35 percent in its U.S. trading debut on Thursday after raising about $153 million in an initial public offering that was priced above the marketing range, indicating strong investor appetite. Shares of the company, the third Canadian cannabis firm to list on a major U.S. exchange, opened at $23.05, compared with the IPO price of $17 per share. The Nasdaq Composite Index (.IXIC) ended down 0.4 percent.
TORONTO, July 18, 2018 /CNW/ - Cronos Group Inc. (NASDAQ:CRON - News) (TSX:CRON.TO - News) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a joint venture partnership with a group of investors led by Bert Mucci (the "Greenhouse Partners"), one of Canada's most sophisticated greenhouse operators and builders. This partnership will function through a newly formed entity, Cronos Growing Company Inc. ("Cronos GrowCo"), which will develop, construct and operate a state-of-the-art purpose-built greenhouse for cannabis production in Kingsville, Ontario.
TORONTO, July 17, 2018 /CNW/ - Cronos Group Inc. (NASDAQ:CRON - News) (TSX:CRON.TO - News) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will announce its financial results and hold its Second Quarter 2018 Earnings Conference Call on Tuesday, August 14, 2018 at 8:30 a.m. EDT. A live audio webcast of the earnings call will be available on the Company's website at https://thecronosgroup.com/investor-relations. Participants may also listen via telephone by dialing 647-427-7450 if calling from Canada, or 1-888-231-8191 if dialing from outside Canada.
HENDERSON, NV / ACCESSWIRE / July 9, 2018 / As a result of Canada's push for legalization, their stock exchanges has seen a flurry of cross-listing activity from companies eager to snap up investment capital and carve out dominant positions in a growing global Cannabis market. Marijuana producers that operate in U.S. states where pot is legal are prevented from public listings in their home country because the drug is prohibited at the federal level, so they turn their focus north for a legal avenue to raise public capital. More recently, several medical marijuana companies that operate solely in Canada, and are able to list in the United States because the drug is legal for medicinal use in their home jurisdictions, have listed or announced intentions to go public in the U.S. in order to tap a bigger pool of investors.
TORONTO , June 28, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ( " Cronos Group " or the " Company ") reports that at its Annual and Special Meeting of Shareholders on ...
TORONTO, June 25, 2018 /CNW/ – Cronos Group Inc. (NASDAQ:CRON - News) (TSX:CRON.TO - News) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a strategic distribution partnership with Delfarma Sp. Founded in 2004, Delfarma is a privately owned pharmaceutical wholesaler and was the first company in Poland to introduce international parallel import of medicinal products from European Economic Area countries.
Major news out of Canada this week brought renewed attention to the legal marijuana industry, with the North American nation becoming just the second country in the world to legalize a statewide recreational cannabis market. Here are two stocks trading on U.S. exchanges to watch now.
NEW YORK, NY / ACCESSWIRE / June 21, 2018 / U.S. markets were mixed Wednesday as global trade concerns continue to be a focus. The Nasdaq and S&P 500 Index posted gains driven by deal making activities ...
Shares of several notable Canadian marijuana companies--including Cronos Group (CRON), Canopy Growth (CGC), and Aurora Cannabis (ACBFF)--moved higher in early morning trading Wednesday on the back of news that recreational marijuana will soon be legal in the country.
It's a big day for recreational marijuana users in Canada, and an even bigger day for marijuana producers.
TORONTO, June 19, 2018 /CNW/ - Cronos Group Inc. (NASDAQ:CRON - News) (TSX:CRON.TO - News) ("Cronos Group" or the "Company"), is pleased to announce that Cronos Australia Pty Ltd. ("Cronos Australia") has been granted a medicinal cannabis Manufacture License by the Australian Office of Drug Control. This license permits manufacturing of cannabinoid based products in Australia and is required for all forms of extraction, refining, concentration and transformation of the cannabis plant. "We are thrilled that Cronos Australia was granted the Manufacture License, circling out the licenses for domestic production which include the medicinal cannabis Cultivation License and Research License," said Mike Gorenstein, CEO of Cronos Group.
NEW YORK, June 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy ...
NEW YORK, NY / ACCESSWIRE / June 14, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Cronos Group Inc. (CRON), a geographically diversified and vertically integrated cannabis group. The Company operates two wholly-owned Canadian licensed producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia. On May 15th, the company announced financial results for the first quarter ending March 31, 2018.
Cronos Group Inc (NASDAQ:CRON), a pharmaceuticals company based in Canada, received a lot of attention from a substantial price increase on the NasdaqGM over the last few months. With manyRead More...
TORONTO, June 8, 2018 /CNW/ - Cronos Group Inc. (NASDAQ:CRON - News) (TSX:CRON.TO - News) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will hold its 2018 Annual and Special Meeting of Shareholders on Thursday, June 28, 2018 at 9:30 a.m. at the offices of Blake, Cassels & Graydon LLP located at 199 Bay Street, Suite 4000, Commerce Court West, Toronto. The Notice of Meeting, Management Information Circular and Form of Proxy are available on the Company's website www.thecronosgroup.com in the governance section. Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents.
With the anticipation of marijuana legalization in Canada in the coming months, most of the sales will be captured in fiscal 2019. In the above chart, you can see that the overall sales estimates for fiscal 2019 for most of the cannabis producers have risen from ~1.1 billion Canadian dollars to ~1.7 billion Canadian dollars over the past six months. Looking at the chart, we see that Cronos Group (CRON), CannTrust Holdings (CNTTF), Hydropothecary (HYYDF), and Aurora Cannabis (ACB) (ACBFF) have had the largest percentage changes in sales revisions over the past six months.
As more and more states legalize both recreational pot and medical weed, it's time to track the best marijuana stocks to buy and watch.
MedMen wants to offer weed delivery and in-store pickup this year and is "actively seeking" ways to expand in the U.S., despite a sales boom that has yet to translate into profits.
Aurora Cannabis Inc. (TSX:ACB) has issued several news releases in May, but I prefer this type to any other.
Similar to what we saw in the previous part of this series, the forward EV-to-EBITDA multiple takes into account the estimates for analysts’ one-year forward EBITDA estimates. Let’s see how this multiple has changed in the past two weeks.
Last week, which ended on May 25, cannabis sector ETFs slipped into negative territory sequentially, with the Horizons Marijuana Life Sciences ETF (HMMJ) closing ~1% lower than the closing on May 18. The ETFMG Alternative Harvest ETF (MJ) fell ~1.7%, and the Horizons Emerging Marijuana Growers Index ETF (HMJR) fell ~1.7%. The Evolve Marijuana ETF (SEED) fell 1.4%.